跳至主要内容
临床试验/NCT02532972
NCT02532972终止不适用

Cochlear Implantation for Treatment of Single-sided Deafness

Dr. Daniel Lee2 个研究点 分布在 1 个国家目标入组 11 人开始时间: 2015年9月最近更新:
适应症

试验速览

阶段
不适用
状态
终止
发起方
入组人数
11
试验地点
2
主要终点
Speech Perception Following Cochlear Implantation Assessed by Consonant-Nucleus-Consonant (CNC) Word Recognition Testing

研究概览

简要总结

This is a research study to determine whether a cochlear implantation (CI) device can improve hearing in people who are deaf in one ear (known as single-sided deafness).

详细描述

The goal of this study is to further investigate the role of CI in treating unilateral hearing loss and associated tinnitus. Single-sided deafness (SSD) afflicts approximately 60,000 new patients per year in the United States. The most common causes of these single-sided losses are sudden sensorineural hearing loss, Meniere's disease, trauma, and vestibular schwannoma. Patients with SSD face significant difficulty with communicating in the presence of background noise and in sound localization. Another significant problem for some SSD patients is tinnitus, which can be incapacitating and for which there are no therapies available that are considered to be of sufficient reliability to become a standard of care. Difficulty hearing in background noise and increased tinnitus can lead to significant frustration in social situations and contribute to increased isolation and a decreased quality of life. Treatment options for single sided deafness in the United States include contralateral routing of signals (CROS) hearing aids, bone-anchored hearing aids (BAHA) and use of assistive devices to improve the signal-to-noise in group situations. The first two devices take sound from the affected ear and transmit it to the unaffected ear. The last device consists of having a speaker wear a microphone and routing the signal directly to the patient's ear at a louder listening level. Although these devices can improve speech understanding in some patients, studies have shown that use of these devices does not ameliorate tinnitus or sound localization difficulties. Recent European studies have demonstrated that cochlear implantation (CI) can provide significant improvements in both perceived hearing ability and measured speech comprehension and localization in adult and pediatric patients with unilateral hearing loss. This suggests that CI may be a more effective option for this patient population than the CROS, BAHA or assistive devices.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • 18 years of age or older with the ability to provide informed consent
  • English as the primary language
  • Medically and psychologically suitable
  • Willing to receive/have received meningitis vaccinations
  • Able to pay for all care received through the study, either through the subject's insurance company or through self-pay
  • Able to comply with study requirements, including travel to the investigational sites
  • Severe to profound sensorineural hearing loss (≥70 dB HL (decibel hearing level) thresholds between 500 and 4000 Hz) in the worse ear with ≤ 20% Consonant-Nucleus-Consonant (CNC) word scores
  • Duration of single-sided deafness ≥ one year
  • Tinnitus localized to the affected ear, both ears, or in the head localized to the affected ear, both ears, or in the head
  • Expected subjects include those with:
  • Unilateral hearing loss secondary to viral or bacterial infection, such as meningitis or labyrinthitis
  • Ménière's disease
  • Sudden sensorineural hearing loss
  • Vascular disease affecting the inner ear
  • A combination of any number of the above conditions

排除标准

  • Duration of single-sided deafness ≥ ten years
  • Pure tone thresholds ≥ 35 dB HL at 500, 1000, 2000, and 4000 Hz in the better ear
  • Consonant-Nucleus-Consonant (CNC) word scores ≤ 70% in the better ear
  • Chronic otitis media in either ear
  • Inner ear malformation in either ear
  • Autoimmune inner ear disease (fluctuation sensorineural hearing loss in either ear)
  • Evidence of retrocochlear pathology, including vestibular schwannoma
  • Unilateral tinnitus in the unaffected ear
  • Cochlear ossification
  • Demonstrated cognitive and/or developmental challenges
  • Major depression or anxiety; post-traumatic stress disorder; substance abuse
  • Medical or psychological conditions that serve as contraindication to surgery
  • Additional handicaps that would prevent or limit participation in evaluations
  • Unrealistic patient or family expectations regarding the benefits, risks, and limitations inherent to the procedure and the prosthetic device
  • Pregnant women: The investigators will specifically ask all women of childbearing age if there is a possibility they are pregnant or trying to become pregnant at the initial clinic visit; any women who are pregnant or actively trying to become pregnant will be excluded. In cases that are questionable on the day of planned surgery, a pregnancy test will be performed as per current Massachusetts Eye & Ear Infirmary anesthesia pre-operative protocols.

结局指标

主要结局

Speech Perception Following Cochlear Implantation Assessed by Consonant-Nucleus-Consonant (CNC) Word Recognition Testing

时间窗: Preop, 1-4 weeks, and 3, 6, and 12 months post-operatively

Ability to recognize words and sentences read by the tester from a set list at a loudness of 65 dB HL. The outcome is measured as a percent score of words recognized. The test takes place in a quiet environment.

Sound Detection Via Pure-tone Threshold Audiometry (PTA)

时间窗: 3, 6 and 12 months post-operatively

Sound field thresholds following cochlear implantation via pure-tone threshold audiometry. Measured in dB HL (decibels hearing level) where a lower number means more sensitive hearing and a higher number means less sensitive hearing.

次要结局

  • Subjective Changes in Tinnitus Following Cochlear Implantation Measured by Tinnitus Handicap Index (THI)(Preop and 12 months post-operatively)

研究者

发起方
Dr. Daniel Lee
申办方类型
Other
责任方
Sponsor Investigator
主要研究者

Dr. Daniel Lee

Director, Pediatric Otology and Neurotology

Massachusetts Eye and Ear Infirmary

研究点 (2)

Loading locations...

相似试验